exosmart™

It was 2018 at a regenerative medicine conference in Milan
when the breakthrough moment occurred.

Mihail Blagoev, Tommaso Brenicci, and Massimo Costa were
reviewing the latest research on exosomes—tiny vesicles
being hailed as the future of medicine.
"Wait a minute, " Mihail turned to his partners." These
exosomes everyone's excited about—aren't they in the plasma we throw away every day during PRP preparation?"
The realization hit them all at once. They weren't just
discarding plasma. They were throwing away billions of
healing particles. Every. Single. Day.

exosmart™: Autologous Exosomes, Uniquely Yours

Every day, thousands of clinics worldwide prepare PRP and discard the plasma supernatant. They're throwing away billions of healing particles worth thousands per treatment.

The Breakthrough That Changes Everything
exosmart™ captures and concentrates what others waste. Using patented ultrafiltration technology, we transform 30mL of plasma into 6-7mL of concentrated therapeutic product containing up to 30 trillion exosomes per milliliter – that's 136 times higher than laboratory reference standards.

This isn't theoretical. We've validated it through:
- Independent laboratory analysis (NTA, Flow Cytometry, TEM, Western Blot)
- MISEV2023 compliance certification
- Phase I clinical safety study (n=30, zero adverse events)
- Over 100,000 procedures performed across 40+ countries

What Makes exosmart™ Unique
Unlike allogenic exosomes (restricted to topical cosmetics) or standard PRP (minimal exosome content), exosmart™ delivers:
- 100% autologous concentration from patient's own blood
CE-MDR Class IIa certification for injectable medical applications
- 20-minute point-of-care processing with standardized 5x concentration
- Multi-specialty applications: orthopedics, aesthetics, hair loss, wound care, surgery